FindTrial
Sign In

Association between postoperative uterotonics administration and postoperative nausea/vomiting in cesarean delivery

Association between postoperative uterotonics administration and postoperative nausea/vomiting in cesarean delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048378
Enrollment
Unknown
Registered
2021-07-06
Start date
2020-10-01
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea/vomiting

Interventions

Case series:Nil

Sponsors

Department of Pharmacy, Guangdong Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: In this single-centre, prospective cohort study, consecutive parturients undergoing cesarean delivery were enrolled from October 2020 to December 2020 with a simplified Apfel score at least 2.

Exclusion criteria

Exclusion criteria: The patient with mental disorders, neuromuscular diseases, bronchial illnesses, gestational diabetes mellitus, body mass index (BMI>30 kg/m2), liver and renal dysfunction, level of sensory block higher than T4, any allergies to anesthesia and uterotonic medication, or severe sinus bradycardia (<50 beats per min [bpm]) was excluded. Additionally, patients with a history of long-term opioid, NSAIDs or sedative medication.

Design outcomes

Primary

MeasureTime frame
postoperative nausea/vomiting;—

Countries

China

Contacts

Public ContactZhikun Liang

Department of Pharmacy, the Sixth Affiliated Hospital of Sun Yat-Sen University

liangzhk9@mail.sysu.edu.cn+86 15018419504

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026